• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (COVINGTON) -1018233 BARD® INLAY OPTIMA® URETERAL STENT WITH NICORE¿ GUIDEWIRE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (COVINGTON) -1018233 BARD® INLAY OPTIMA® URETERAL STENT WITH NICORE¿ GUIDEWIRE Back to Search Results
Catalog Number 786426
Medical Device Problem Code Wrong Label (4073)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 10/08/2023
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The investigation is still in progress.Once the investigation is complete a supplemental report will be filed.H11: section a through f - the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event or Problem Description
It was reported that the 6fr bracket was included in the 786426 (4.5fr * 26cm) bracket sets.There were 15 unopened sets in total.
 
Additional Manufacturer Narrative
The reported event is confirmed manufacturing related.Visual evaluation noted received 15 kits closed original packaging.8 samples were unpacked and found to be containing the incorrect stent as outside package indicated stent size as 4.7 fr x 26cm.Package contained 6 fr x 26 cm stent.Also received one photo samples showing top view of 15 stent kits in original closed packaging.Based on physical sample received the product does not meet specifications.Although an exact root cause could not be determined a potential root cause could be wrong line clearance.A dhr review did not show any problems or conditions that would have contributed to the reported event.A labelling review is not required as labelling would not have prevented the reported event.H11: section a through f - the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : the actual/suspected device was inspected.
 
Event or Problem Description
It was reported that the 6fr bracket was included in the 786426 (4.5fr * 26cm) bracket sets.There were 15 unopened sets in total.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BARD® INLAY OPTIMA® URETERAL STENT WITH NICORE¿ GUIDEWIRE
Common Device Name
URETERAL STENT
Manufacturer (Section D)
C.R. BARD, INC. (COVINGTON) -1018233
8195 industrial blvd
covington 30014
Manufacturer (Section G)
C.R. BARD, INC. (COVINGTON) -1018233
8195 industrial blvd
covington 30014
Manufacturer Contact
xeeroy rada
8195 industrial blvd
covington 30014
7707846100
MDR Report Key18021570
Report Number1018233-2023-07697
Device Sequence Number18061779
Product Code FAD
UDI-Device Identifier10801741015042
UDI-Public(01)10801741015042
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
K043193
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Other,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 01/16/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date09/24/2024
Device Catalogue Number786426
Device Lot NumberNGGV4106
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/25/2023
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 10/08/2023
Supplement Date Received by Manufacturer01/17/2024
Initial Report FDA Received Date10/27/2023
Supplement Report FDA Received Date01/18/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured09/02/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-